Study pregnancy outcomes in lupus and antiphospholipid syndrome
Part of Immune system & allergy, Skin clinical trials.
This study looks for factors that may predict how pregnancy turns out in people with lupus (SLE) and/or antiphospholipid syndrome (APS). It may help doctors better understand what to monitor in early pregnancy to support healthier outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently pregnant with a live baby inside the uterus and you are within the first trimester
- Your gestational week limit depends on your APS antibody status (if you have APS antibodies, up to 18 weeks; if not, up to 12 weeks)
- You are age 18–45 (or under 18 with a parent/guardian who can consent)
- Your blood count (hematocrit) is above 26%
- If you have APS antibodies, you meet specific blood test thresholds for aCL, anti-beta2GP1, and/or lupus anticoagulant
- If you are in the control group, you have had at least one prior successful pregnancy and no recent pregnancy losses beyond allowed limits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic (inherited) risk factors in people who have antiphospholipid antibodies and related symptoms. Your results may help researchers better predict who is at risk and improve care for antiphospholipid antibody syndrome.
This Phase 1 study looks at a treatment plan for people with systemic lupus (SLE) during pregnancy and tracks health outcomes for mother and baby. It may help doctors learn how to manage SLE safely in pregnancy and what results to expect.
This study looks at lab results and clinic information in people who have antiphospholipid antibodies. The goal is to better understand these antibody-positive conditions and what happens over time, which may help improve care.
This trial looks at people who have symptoms of antiphospholipid syndrome (APS) but test negative for the usual antibodies. It will compare these patients to those with positive antibody tests to better understand the condition and improve diagnosis and treatment.
This study tracks the health of pregnant women with moderate to severe lupus who have been treated with anifrolumab, compared to those treated with other lupus medications. It aims to understand how these treatments affect both mother and baby.
This study looks at how platelet counts change over time in people with antiphospholipid syndrome (APS), a condition that can cause blood clots and pregnancy problems. It may help doctors better understand and manage low platelets in APS patients.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.